Risk factors for acute variceal bleeding in acute-on-chronic liver failure and its influence on prognosis

Wanshu LIU; Lijun SHEN; Qinghui ZHAI; Shaojie XIN; Shaoli YOU

doi:10.3969/j.issn.1001-5256.2022.11.018

Volume 38 Issue 11

Nov. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(11): 2532-2536

PDF( 2154 KB)

Risk factors for acute variceal bleeding in acute-on-chronic liver failure and its influence on prognosis

DOI: 10.3969/j.issn.1001-5256.2022.11.018

Department of Liver Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China

Research funding:

The 13th Five-Year National Science and Technology Major Project for Infectious Diseases (2017ZX10203201-004)

More Information

Corresponding author: YOU Shaoli, youshaoli1972@163.com(ORCID: 0000-0001-8689-8509)
Received Date: 2022-05-05
Accepted Date: 2022-06-20
Published Date: 2022-11-20

Abstract

Abstract

Objective To investigate the risk factors for acute variceal bleeding (AVB) in acute-on-chronic liver failure (ACLF) and its influence on prognosis. Methods A total of 1409 ACLF patients who were admitted to The Fifth Medical Center of Chinese PLA General Hospital from 2009 to 2015 were followed up for 6 months, and according to the presence or absence of AVB, they were divided into AVB group and non-AVB group. The Student's t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups. The Kaplan-Meier curves were plotted and the Log-rank test was performed to analyze mortality rate and progression during follow-up, and a binary Logistic regression analysis was used to investigate the risk factors for AVB. Results Among these 1409 patients, 167 (11.85%) experienced AVB. The 30-day survival rate was 43.42% in the AVB group and 67.79% in the non-AVB group (χ²=33.558, P < 0.001), and the 180-day survival rate was 18.91% in the AVB group and 53.97% in the non-AVB group (χ²=76.881, P < 0.001). The Log-rank test showed significant differences in 30- and 180-day survival rates between the AVB group and the non-AVB group (χ²=40.950 and 89.320, both P < 0.05). The Logistic regression analysis showed that pleural effusion (odds ratio [OR]=1.522, 95% confidence interval [CI]: 1.071-2.162, P=0.019), acute kidney injury (AKI) (OR=2.201, 95%CI: 1.415-3.426, P < 0.001), ABC subtype of ACLF (OR=2.491, 95%CI: 1.489-4.168, P=0.001), ACLF stage (OR=2.403, 95%CI: 1.687-3.421, P < 0.001), and urea(OR=2.567, 95%CI: 1.570-4.196, P < 0.001)were independently associated with AVB in ACLF patients. Conclusion AVB is an important influencing factor for the short-term survival of ACLF patients, and pleural effusion, AKI, BC subtype of ACLF, advanced ACLF, and urea are independent risk factors for the onset of AVB.
- Acute-On-Chronic Liver Failure,
- Varicose Veins,
- Risk Factors,
- Prognosis

FullText(HTML)

References(20)

References

[1]	SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update[J]. Hepatol Int, 2019, 13(4): 353-390. DOI: 10.1007/s12072-019-09946-3.
[2]	JOSHI D, O'GRADY J, PATEL A, et al. Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with high-grade hepatic encephalopathy[J]. Liver Int, 2014, 34(3): 362-366. DOI: 10.1111/liv.12257.
[3]	SHIN J, YU JH, JIN YJ, et al. Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding[J]. Clin Mol Hepatol, 2020, 26(4): 540-553. DOI: 10.3350/cmh.2020.0034.
[4]	TREBICKA J, GU W, IBÁÑEZ-SAMANIEGO L, et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS[J]. J Hepatol, 2020, 73(5): 1082-1091. DOI: 10.1016/j.jhep.2020.04.024.
[5]	AL-MAHTAB M, AKBAR SM, GARG H. Influence of variceal bleeding on natural history of ACLF and management options[J]. Hepatol Int, 2016, 10(3): 436-439. DOI: 10.1007/s12072-015-9677-2.
[6]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Diagnostic and treatment guidelines for liver failure (2018 version)[J]. J Chin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[7]	MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144(7): 1426-1437. e1-9. DOI: 10.1053/j.gastro.2013.02.042.
[8]	GARCIA-TSAO G, ABRALDES JG, BERZIGOTTI A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology, 2017, 65(1): 310-335. DOI: 10.1002/hep.28906.
[9]	HUANG Y, ZHANG W, XIANG H, et al. Treatment strategies in emergency endoscopy for acute esophageal variceal bleeding (CHESS1905): A Nationwide Cohort Study[J]. Front Med (Lausanne), 2022, 9: 872881. DOI: 10.3389/fmed.2022.872881.
[10]	KAMATH PS, KIM WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD)[J]. Hepatology, 2007, 45(3): 797-805. DOI: 10.1002/hep.21563.
[11]	KIM WR, BIGGINS SW, KREMERS WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list[J]. N Engl J Med, 2008, 359(10): 1018-1026. DOI: 10.1056/NEJMoa0801209.
[12]	GARG H, KUMAR A, GARG V, et al. Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure[J]. J Gastroenterol Hepatol, 2013, 28(8): 1361-1367. DOI: 10.1111/jgh.12191.
[13]	KAR R, KAR SS, SARIN SK. Hepatic coagulopathy-intricacies and challenges; a cross-sectional descriptive study of 110 patients from a superspecialty institute in North India with review of literature[J]. Blood Coagul Fibrinolysis, 2013, 24(2): 175-180. DOI: 10.1097/MBC.0b013e32835b2483.
[14]	European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(2): 406-460. DOI: 10.1016/j.jhep.2018.03.024.
[15]	AMITRANO L, GUARDASCIONE MA, MARTINO R, et al. Hypoxic hepatitis occurring in cirrhosis after variceal bleeding: still a lethal disease[J]. J Clin Gastroenterol, 2012, 46(7): 608-612. DOI: 10.1097/MCG.0b013e318254e9d4.
[16]	KUMAR A, DAS K, SHARMA P, et al. Hemodynamic studies in acute-on-chronic liver failure[J]. Dig Dis Sci, 2009, 54(4): 869-878. DOI: 10.1007/s10620-008-0421-9.
[17]	MEHTA G, MOOKERJEE RP, SHARMA V, et al. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure[J]. Liver Int, 2015, 35(3): 724-734. DOI: 10.1111/liv.12559.
[18]	TREBICKA J, GU W, IBÁÑEZ-SAMANIEGO L, et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS[J]. J Hepatol, 2020, 73(5): 1082-1091. DOI: 10.1016/j.jhep.2020.04.024.
[19]	HEO NY. Acute-on-chronic liver failure: A predictor of poor prognosis in patients with variceal bleeding or a risk factor for variceal bleeding?[J]. Clin Mol Hepatol, 2020, 26(4): 487-488. DOI: 10.3350/cmh.2020.0209.
[20]	KUMAR R, KERBERT A, SHEIKH MF, et al. Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding[J]. J Hepatol, 2021, 74(1): 66-79. DOI: 10.1016/j.jhep.2020.06.010.

Relative Articles

[1]	Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119
[2]	Lijingzi WANG, Pei LI, Ye ZHANG, Jianqi LIAN, Lan ZHANG, Shasha WU, Congmin SHI, Xiao DANG. Risk factors for pulmonary infection in patients with acute-on-chronic liver failure and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2024, 40(6): 1196-1202. doi: 10.12449/JCH240620
[3]	Di WU, Dahua DAI, Wenmei LIANG, Bao FU, Xiaoyun FU. Clinical features of acute pancreatitis in pregnancy and related risk factors[J]. Journal of Clinical Hepatology, 2024, 40(5): 1009-1015. doi: 10.12449/JCH240522
[4]	Wenling LUO, Yu ZENG, Xuemei ZHANG, Yunjian SHENG. Influence of metabolism-related factors on the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2024, 40(10): 1985-1991. doi: 10.12449/JCH241010
[5]	Shihua ZHANG, Chengzhi BAI, Chunyan LI, Limao XU, Huaqian XU, Shanhong TANG. Risk factors for the prognosis of elderly patients with hepatitis B virus-related acute-on-chronic liver failure and construction of a nomogram model for risk prediction[J]. Journal of Clinical Hepatology, 2024, 40(10): 1976-1984. doi: 10.12449/JCH241009
[6]	Qian ZHANG, Tao HAN. Prognostic evaluation of acute－on－chronic liver failure[J]. Journal of Clinical Hepatology, 2023, 39(10): 2301-2306. doi: 10.3969/j.issn.1001-5256.2023.10.006
[7]	Xiaohua LIU, Shujuan YANG, Yushan LIU, Juan LI, Qiao ZHANG, Yamin WANG, Taotao YAN, Yuan YANG, Yingren ZHAO, Yingli HE. Value of peripheral blood lymphocyte count in evaluating the short－term prognosis of patients with acute－on－chronic liver failure[J]. Journal of Clinical Hepatology, 2023, 39(10): 2383-2389. doi: 10.3969/j.issn.1001-5256.2023.10.016
[8]	Shanshan LI, Manman XU, Zhongping DUAN, Yu CHEN. Risk factors for liver cirrhosis in acute-on-chronic liver failure patients without liver cirrhosis in the convalescence stage[J]. Journal of Clinical Hepatology, 2021, 37(12): 2824-2829. doi: 10.3969/j.issn.1001-5256.2021.12.019
[9]	Xiaoyan LIU, Jinhua HU, Chen LI, Jing CHEN, Jingjing TONG, Chongdan GUAN, Yuhui PENG, Peng NING, Lilong YAN, Haibin SU. Clinical features of patients with acute-on-chronic liver failure and bacterial infection and influencing factors for prognosis[J]. Journal of Clinical Hepatology, 2021, 37(9): 2148-2152. doi: 10.3969/j.issn.1001-5256.2021.09.028
[10]	Chenrui LIU, Yaping LI, Sen LUO, Dandan FENG, Fengping WU, Song ZHAI, Shuangsuo DANG. Influencing factors for the short-term prognosis of patients with HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2021, 37(1): 56-62. doi: 10.3969/j.issn.1001-5256.2021.01.012
[11]	Dongqing ZHANG, Ruidan ZHENG, Minghua LIN, Wenjun WU, Shenglong LIN, Xiangmei WANG, Huaxi MA, Qin LI, Hanhui YE, Haibing GAO. Influencing factors for the 90-day prognosis of patients with HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2021, 37(10): 2316-2319. doi: 10.3969/j.issn.1001-5256.2021.10.011
[12]	Yang ShuJuan, Tian Zhen, He YingLi, Zhao YingRen, Zhang Jing, Lu: HengYi, Song HongBo. Predisposing factors for acute-on-chronic liver failure and their influence on prognosis[J]. Journal of Clinical Hepatology, 2020, 36(1): 128-131. doi: 10.3969/j.issn.1001-5256.2020.01.028
[13]	Wang JiaXin, Cheng Na, Xiang TianXin, Li ShuYue, Xiao JinPing, Wu XiaoPing. Establishment and evaluation of short-term prognostic model for hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(6): 1299-1303. doi: 10.3969/j.issn.1001-5256.2019.06.023
[14]	Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022
[15]	Li Ying, Zhan Jing, Wang ZhongFeng. Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2017, 33(3): 497-501. doi: 10.3969/j.issn.1001-5256.2017.03.020
[16]	Shi XinXing, Zhang YanQiong, Zhu Peng, Yan GuoHua, Zhang ZhangJiang, Wang YuMing. Prognostic risk factors in patients with hepatitis B virus- related acute- on- chronic liver failure[J]. Journal of Clinical Hepatology, 2016, 32(4): 700-705. doi: 10.3969/j.issn.1001-5256.2016.04.018
[17]	Wu XiaoQing, Wan Hong. Causes of liver failure and impact analysis of prognostic risk factors[J]. Journal of Clinical Hepatology, 2013, 29(4): 294-296+304.
[18]	Lu: RiYing, Li ShiXiong, Wu JiZhou, Zhu YuJia, Fu ShaoPing. Development of a prognostic factors model for severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(10): 789-792.
[19]	Zhang DongQing, Chen Li, Gan QiaoRong, Zhou Rui, Huang JianRong, Pan Chen. Prognostic factors for hepatitis B acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 740-743.
[20]	Ding HuiGuo, Gao GuiJu, Chen Tao, Jin Rui. Prognosis of Severe Types of Virous Hepatitis: Study on Mutiple Risk Factors.[J]. Journal of Clinical Hepatology, 2002, 18(5): 297-299.

Supplements(0)

Cited By

Cited by
Periodical cited type(0)
Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (587) PDF downloads(41)

Risk factors for acute variceal bleeding in acute-on-chronic liver failure and its influence on prognosis

DOI: 10.3969/j.issn.1001-5256.2022.11.018

Abstract

References

Relative Articles

Cited by

Periodical cited type(0)

Other cited types(1)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Risk factors for acute variceal bleeding in acute-on-chronic liver failure and its influence on prognosis

DOI: 10.3969/j.issn.1001-5256.2022.11.018

Abstract

References

Relative Articles

Cited by

Periodical cited type(0)

Other cited types(1)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content